skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The utility of troponin measurement to detect myocardial infarction: review of the current findings

Review

(3030) Views  (1823) Full article downloads

Authors: Melissa A Daubert, Allen Jeremias

Published Date August 2010 Volume 2010:6 Pages 691 - 699
DOI: http://dx.doi.org/10.2147/VHRM.S5306

Melissa A Daubert, Allen Jeremias
Division of Cardiovascular Medicine, Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, USA

Abstract: Myocardial infarction (MI) is defined by the presence of myocardial necrosis in combination with clinical evidence of myocardial ischemia. Cardiac troponins are regulatory proteins within the myocardium that are released into the circulation when damage to the myocyte has occurred. Therefore, serum troponin is an exquisitely sensitive marker of myocardial injury and is necessary for establishing the diagnosis of MI. High-sensitivity troponin assays are improving the diagnostic accuracy and rapid detection of myocardial infarction. The early identification of MI is vital for the institution of anti-thrombotic therapy to limit myocardial damage and preserve cardiac function. Troponin has both diagnostic and prognostic significance in the setting of acute coronary syndrome (ACS). Increased troponin levels in the absence of ACS should prompt an evaluation for an alternative, non-thrombotic mechanism of troponin elevation and direct management at the underlying cause. This review describes the role of troponin in the evaluation of patients with suspected myocardial infarction.

Keywords: myocardial infarction, troponin, high-sensitivity assays







Readers of this article also read:

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine
Practical recommendations for treatment of hypertension in older patients
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
Risk assessment and aspirin use in Asian and Western populations
False elevation of cardiac markers: importance of recognition
Troponin elevation in conditions other than acute coronary syndromes
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University